Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
(2021) 11:e043054
Coding was conducted independently by two researchers, and discrepancies were resolved through discussion to reach consensus
One-Year Results Longer-term studies assess how much progress was maintained, whether weight reduction continued, how metabolic markers changed, and how well participants tolerated treatment over time
The mean age was 46.3 years (SD 6.4)
Weight Loss vs
Right after this, semaglutide became available with the indication of diabetes in 2017, and then in 2020, its treatment for obesity was also authorized
US$ 26.48
US$ 24.18
US$ 23.83
US$ 27.56
US$ 21.42
